Psych Vivas · General adult psychiatry — early psychosis pathway
First-episode psychosis — structured clinical viva
Fellowship viva on FEP pathway: DUP, organic work-up, OPUS/RAISE, low-dose starts, maintenance after remission, cannabis, IPS, and communication with family.
On this page & tools
Target exams
Interpretation
Reveal interpretation
Assessment spine. Risk (suicide, violence, vulnerability), MSE with examples, collateral, substance timeline, DUP about 4 months of frank psychosis (already prognostic), capacity/legal status under local statute, and medical exclusion. Observations and glucose if not done; baseline metabolic panel and ECG before antipsychotic.[2]
"Is this schizophrenia forever?" Answer with pathway language: this is first-episode psychosis; the operational label may evolve with duration; many people improve substantially with early multi-element care; avoid fatalism while remaining honest that some need longer treatment.[1]
"Strongest tablet now?" FEP responds to lower doses; high-dose polypharmacy increases harm. Name a first-line plan (e.g. aripiprazole 10 mg daily) with monitoring. Clozapine is for treatment resistance after adequate trials, not automatic first dose.[1]
Maintenance duration. After remission, early stop carries high recurrence risk; counsel continued treatment typically for at least 1–2 years with shared decision-making; any taper is supervised with early-warning plans.[3]
University. Temporary adjustment may help; automatic abandonment is wrong. Offer IPS / supported education integrated with the team — vocational recovery is evidence-based, not a luxury after "full cure."[4]
Evidence names for the examiner. Marshall/Perkins on DUP; OPUS; RAISE-ETP; Correll EIS meta-analysis; Zipursky discontinuation risk; Killackey IPS; family intervention evidence.[1][2][4]
Key points
[1] [3]References
- [1]Kane JM, Robinson DG, Schooler NR, et al. Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program Am J Psychiatry, 2016.PMID 26481174
- [2]Marshall M, Lewis S, Lockwood A, et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review Arch Gen Psychiatry, 2005.PMID 16143729
- [3]Zipursky RB, Menezes NM, Streiner DL Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review Schizophr Res, 2014.PMID 23972821
- [4]Killackey E, Allott K, Jackson HJ, et al. Individual placement and support for vocational recovery in first-episode psychosis: randomised controlled trial Br J Psychiatry, 2019.PMID 30251616